The process of formation of red blood cells is termed as erythropoiesis. Erythropoiesis takes place in the bone marrow.
The process of formation of red blood cells is termed as erythropoiesis. Erythropoiesis takes place in the bone marrow. Agents promoting synthesis of red blood cells are known as erythropoiesis-stimulating agents. These are recombinant versions of a hormone erythropoietin, which is naturally produced by the kidneys and is responsible for stimulating bone marrow for red blood cells synthesis. Erythropoiesis-stimulating agents are recommended for the treatment of anemia. Hemoglobin is a substance in red blood cells, which carries oxygen around the body.
Read Report Overview - https://www.transparencymarketresearch.com/erythropoiesis-stimulating-agents-market.html
When the body does not receive enough oxygen because of less number of red blood cells, it results into anemia. Anemia is highly associated with chronic kidney disease, and the overall prevalence rate of the disease in the U.S. is 15%. About 50% of the population with advanced diseases develop anemia. Hence, besides the use of dialysis, the development and use of erythropoiesis-stimulating agents are significant advancements in treating patients with chronic kidney disease. These agents were introduced in 1980s and became a popular treatment for anemia.
In cases wherein patients cannot undergo blood transfusions, it becomes necessary to give them erythropoiesis-stimulating agents, also known as recombinant erythropoietin. Epoetin alfa (under the brand name Procrit and Epogen) and darbepoetin alfa (under the brand name Aranesp) are two agents approved by the FDA for treating anemia caused due to chemotherapy, chronic kidney disease, and certain treatments for HIV. These agents are given as subcutaneous injections or as intravenous injections. The dose frequency, depending on the patient’s condition, can vary from once in a week or once every two weeks.
Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=30506
Increasing incidence of anemia cases worldwide is driving the growth of the global erythropoiesis-stimulating agents market. In addition, rising awareness about erythropoiesis-stimulating agent therapies is contributing to the market growth. The demand for erythropoiesis-stimulating agents is rapidly increasing due to rising prevalence of chronic kidney disease and cancer and growing demand for cheaper erythropoietin drugs. Efforts are taken by researchers and pharmaceutical companies to develop novel erythropoietin drugs. However, stringent regulatory norms and side effects such as hypersensitivity, hypertension, seizures, or convulsions associated with erythropoiesis-stimulating agents are restraining the market growth.
The global erythropoiesis synthesis market can be broadly divided into two segments, namely biologics and biosimilars. On the basis of product type, the market can be segmented as epoetin-alfa, epoetin-beta, epoetin-zeta, epoetin-omega, epoetin-lambda, epoetin-delta, and darbepoetin-alfa.
Request for Analysis of COVID-19 Impact on Erythropoiesis-stimulating Agents Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=30506
The latest product marketed as erythropoiesis-stimulating agent is darbepoetin, and the market for this agent is expected to grow during the forecast period. In terms of application, the market is segmented as erythropoietin agents used in treatment of kidney disorders, cancer, anti-retroviral treatment, neural diseases, and anemia caused as a side effect of HIV.
Geographically, the global erythropoiesis-stimulating agents market is distributed over North America, Europe, Asia Pacific, Middle East, Africa, and South America. North America consists of the U.S., Canada, and Mexico. European market for erythropoietin stimulating agents includes countries like U.K., Germany, France, Italy, Spain etc.
Enquiry Before Buying - https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=30506
The erythropoietin stimulating agents market in Asia Pacific includes countries such as China, Japan, India, South Korea, Australia & New Zealand, and rest of Asia Pacific. North America accounted for the largest market value, but Asia Pacific is expected to expand at a high CAGR during the forecast period. The emerging economies and new products with better efficacy will be a big opportunity for the erythropoietin stimulating agents market.
Key players operating in the global market include Biocon, Johnson & Johnson, Teva Pharmaceutical Industries Ltd., Intas Pharmaceuticals, Amgen Inc., Hoffmann-La Roche, Biosidus, and Ranbaxy Laboratories Ltd.
Browse more Reports by Transparency Market Research:
Assisted Reproductive Technology Market: The global assisted reproductive technology market is presented in the form of different segments, which are based on many critical parameters such as technology, procedure, end user, and region. In terms of technology, the market is divided into artificial insemination, in vitro fertilization, surrogacy, and others.
Vascular Stents Market: Rise in preference for minimally invasive treatment options, such as angioplasty and other percutaneous coronary intervention (PCI) procedures in the region, is expected to drive the vascular stents market in the region during the forecast period. The market in Asia Pacific is likely to expand at a high CAGR of ~6% from 2019 to 2027.
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
Contact
Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453